GRANULOMATOUS POLYANGIITIS

Clinical trials for GRANULOMATOUS POLYANGIITIS explained in plain language.

Never miss a new study

Get alerted when new GRANULOMATOUS POLYANGIITIS trials appear

Sign up with your email to follow new studies for GRANULOMATOUS POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

One-Shot cell therapy tested for devastating autoimmune diseases

Disease control Ongoing

This is an early safety study testing a single dose of an experimental cell therapy called SC291. It is for adults with severe forms of lupus or a blood vessel disease called ANCA-associated vasculitis that have not improved with at least two prior treatments. The goal is to see …

Matched conditions: GRANULOMATOUS POLYANGIITIS

Phase: PHASE1 • Sponsor: Sana Biotechnology • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

GRANULOMATOUS POLYANGIITIS

Get alerted when new GRANULOMATOUS POLYANGIITIS trials appear

One-Shot cell therapy tested for devastating autoimmune diseases